niraparib,sintilimab
Showing 1 - 1 of 1
Nasopharyngeal Carcinoma Trial in Guangzhou (Niraparib,Sintilimab)
Recruiting
- Nasopharyngeal Carcinoma
- Niraparib,Sintilimab
-
Guangzhou, Guangdong, ChinaLi zhang
Dec 6, 2021